ASND
Ascendis Pharma A/S
NASDAQ · Healthcare · Biotechnology · DK
$229.95
+2.09%Forward multiples
Based on analyst estimates
- P/E forward
- 27.49x
- P/E 2026E
- 14.00x
- P/E 2027E
- 22.36x
- P/E 2028E
- 14.23x
- P/S forward
- 7.16x
Trailing multiples
Trailing twelve months
- P/E TTM
- 16.94x
- PEG TTM
- —
- Price / book
- 9.39x
- Price / sales
- 12.79x
- Price / cash flow
- 38.39x
Enterprise value
- Enterprise value
- $14.7B
- EV / sales
- 12.45x
- EV / EBITDA
- 168.02x
- EV / EBIT
- 119.93x
- Market cap
- $15.1B
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026